Efficiency and tolerability of drug AEvit in complex treatment of patients with atopic dermatitis

Abstract

Objective — to evaluate the effectiveness and tolerability of drug AEvit in the complex treatment of patients with atopic dermatitis (AD). Materials and methods. We observed 100 patients with AD, who were randomized into the main (50 patients) and control (50 patients) groups. Demographic and anamnestic data were collected from all patients, clinical signs of AD on the SCORAD (Severity scoring of atopic dermatitis: Consensus Report of the European Task Force on Аtopic Dermatitis) scale were evaluated, general clinical biochemical studies were performed. Inclusion criteria were: male and female gender, age from 18 to 70 years, diagnosis of AD in the stage of exacerbation established on the basis of the criteria of Hanifin and Rajka1; moderate or severe degree of the disease (30—70 points on the SCORAD scale); affected area < 30 % of the body surface. Patients underwent standard therapy. Patients of the main group additionally took AEvit, 1 capsule per day after meals for 30 days. Statistical processing of the obtained results was carried out with the use of methods of biometric analysis implemented in the packages of licensed programs Excel 2003 and Statistica 6.1 (StatSoft Inc., serial number AGAR909E415822FA). Results and discussion. Analysis of the anamnestic data allowed establishing the duration of the disease: up to 1 year — in 27 patients, 1—5 years — in 45 patients, 5—10 years — in 21 patients, more than 10 years — in 7 patients. There were 35 (35 %) men and 65 (65 %) women among the examined patients with AD. The duration of the disease according to the anamnestic history was 52.8 years in the main group, and 4.18 — in the control group. After the course of treatment, 28 (56 %) patients of the main group and 19 (38 %) patients of the control group achieved complete clinical remission of the disease. In all other cases, a significant reduction in the SCORAD index was achieved. Conclusions. There was a statistically significant decrease in the severity of the symptoms of the disease in both groups, but it was much more pronounced in the group of patients who used AEvit in the complex treatment.

Authors and Affiliations

A. D. Dyudyun, N. M. Polion, S. G. Svirid, L. V. Lappa

Keywords

Related Articles

Aspects of pharmacokinetics of Cidipol drug while rectal and dermal application as basis for its clinical use

Cidipol is a combination drug in the form of a solution of chlorine­brown aldehyde in dimexide and polyethylene glycol (PEG-400). Objective — to study the pharmacokinetics of Сidipol drug while rectal and dermal applica...

Dynamics of clinical manifestations and blood serum content of specific cytokines in patients with rosacea treated by means of integrated therapy

Objective — to determine and analyze the dynamics of clinical manifestations and blood serum content of specific cytokines in patients with rosacea treated by means of integrated therapy. Materials and methods. The stud...

Modern complex treatment of microsporia

Objective — to increase the effectiveness of the treatment of children with microsporia by using Breveluck probiotic-vitamin complex in the complex therapy. Materials and methods. 55 sick children aged from 1 to 13 year...

Lipid metabolism in skin of patients with psoriasis and prospects for studying the significance of its disorders in the pathogenesis of dermatosis

Objective — to analyze the characteristics of the spectrum of lipids in the skin of patients with psoriasis and determine the value of lipid metabolism disorders in the pathogenesis of dermatosis. Materials and methods....

Acariases. Clinical cases from practice

Objective — to conduct the review of literary data of mites, the most significant in medical terms, and to present clinical cases of own observations from practice of dermatological diseases which are caused by acariform...

Download PDF file
  • EP ID EP615174
  • DOI 10.30978/UJDVK2019-2-81
  • Views 79
  • Downloads 0

How To Cite

A. D. Dyudyun, N. M. Polion, S. G. Svirid, L. V. Lappa (2019). Efficiency and tolerability of drug AEvit in complex treatment of patients with atopic dermatitis. Український журнал дерматології, венерології, косметології, 0(2), 81-87. https://europub.co.uk/articles/-A-615174